Chris Wittenborn
Trading-Equity bei Frazier Life Sciences Management LP
Profil
Mr. Christopher D.
Wittenborn is a Trader at Frazier Life Sciences Management LP.
He joined the Frazier Life Sciences team as a Trader in April 2021 and focuses on trade execution as part of Frazier’s public portfolio management.
Prior to joining Frazier, he was the CEO of a FINRA registered Broker Dealer that garnered one of the first approvals for transacting in digitized private market securities on an SEC Registered Alternative Trading System (“ATS”).
Previously, he was a trader at Point72 Asset Management where he focused on public Biotechnology companies.
Before Point72, he was a Director at Leerink Partners (now SVB Leerink), where he spent six years focused on market making in Biotech and Generic Pharmaceuticals companies.
He began his career in Special Situations Research and transitioned to trading by managing the pre- and post-trade analytics for a program trading desk responsible for transacting on behalf of large pension funds.
Mr. Wittenborn earned a Bachelor of Science (Finance) in Business at the University of Colorado at Boulder where he was a member of the Dean’s Cabinet for the Business School.
Aktive Positionen von Chris Wittenborn
| Unternehmen | Position | Beginn |
|---|---|---|
Frazier Life Sciences Management LP
 Frazier Life Sciences Management LP Investment ManagersFinance Frazier Life Sciences Management LP (Frazier Life Sciences) is a private investment manager headquartered in Menlo Park, California. The firm was founded in 2021 as a newly spun off company from Frazier Management LLC. They are principally owned by Jamie Topper and Patrick Heron. Frazier Life Sciences provides discretionary investment management services to US private investment funds, Frazier Life Sciences Funds. | Trading-Equity | 01.04.2021 |
Ehemalige bekannte Positionen von Chris Wittenborn
| Unternehmen | Position | Ende |
|---|---|---|
Wm Smith Securities, Inc.
 Wm Smith Securities, Inc. Investment Banks/BrokersFinance Wm Smith Securities, Inc., the brokerage arm of Wm Smith & Co. is a broker/dealer headquartered in Denver. The firm was founded in October of 1993 and offers a full array of investment services. They provide fundamental equity research to a select group of institutional clients from both the traditional and alternative investment arena. The firm primarily focuses on special situations with an emphasis on under-followed and under-valued companies. They are a member of the SIPC. | Analyst-Equity | 24.08.2010 |
Ausbildung von Chris Wittenborn
| The University of Colorado | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Wm Smith Securities, Inc.
Wm Smith Securities, Inc. Investment Banks/BrokersFinance Wm Smith Securities, Inc., the brokerage arm of Wm Smith & Co. is a broker/dealer headquartered in Denver. The firm was founded in October of 1993 and offers a full array of investment services. They provide fundamental equity research to a select group of institutional clients from both the traditional and alternative investment arena. The firm primarily focuses on special situations with an emphasis on under-followed and under-valued companies. They are a member of the SIPC. | Finance |
Frazier Life Sciences Management LP
Frazier Life Sciences Management LP Investment ManagersFinance Frazier Life Sciences Management LP (Frazier Life Sciences) is a private investment manager headquartered in Menlo Park, California. The firm was founded in 2021 as a newly spun off company from Frazier Management LLC. They are principally owned by Jamie Topper and Patrick Heron. Frazier Life Sciences provides discretionary investment management services to US private investment funds, Frazier Life Sciences Funds. | Finance |
